Xylem Sees Unusually Large Options Volume (NYSE:XYL)

Xylem Inc. (NYSE:XYL) was the target of unusually large options trading activity on Thursday. Traders purchased 20,508 call options on the stock. This is an increase of 771% compared to the average daily volume of 2,355 call options.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. Stifel Nicolaus dropped their price target on shares of Xylem from $141.00 to $114.00 and set a “buy” rating for the company in a research report on Wednesday. UBS Group cut their target price on shares of Xylem from $112.00 to $99.00 and set a “neutral” rating for the company in a research note on Thursday. Citigroup cut their price target on Xylem from $148.00 to $130.00 and set a “buy” rating for the company in a report on Wednesday. Mizuho set a $99.00 target price on Xylem in a research report on Wednesday. Finally, Royal Bank Of Canada dropped their target price on shares of Xylem from $135.00 to $125.00 and set an “outperform” rating for the company in a research report on Wednesday. Nine research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Xylem presently has a consensus rating of “Hold” and a consensus price target of $121.31.

Insider Activity

In other Xylem news, Director D Koch bought 11,000 shares of the stock in a transaction on Thursday, October 29th. The shares were purchased at an average price of $89.60 per share, with a total value of $985,600.00. Following the acquisition, the director directly owned 12,247 shares of the company’s stock, valued at $1,097,331.20. This represents a 882.12% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Corporate insiders own 0.32% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the stock. William Mack & Associates Inc. bought a new stake in shares of Xylem during the 3rd quarter valued at approximately $25,000. Dunhill Financial LLC acquired a new position in shares of Xylem in the second quarter worth approximately $30,000. Avalon Trust Co acquired a new position in Xylem in the second quarter valued at $35,000. Orion Capital Management LLC acquired a new position in shares of Xylem during the 2nd quarter valued at $35,000. Finally, Aventus Investment Advisors Inc. increased its holdings in shares of Xylem by 66.7% during the second quarter. Aventus Investment Advisors Inc. now owns 300 shares of the industrial products company’s stock valued at $35,000 after acquiring an additional 120 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors.

Xylem Stock Up 2.8%

Shares of XYL traded up $2.51 on Thursday, hitting $90.74. The company’s stock had a trading volume of 4,918,434 shares, compared to its average volume of 2,172,384. The firm’s fifty day moving average price is $105.98 and its 200-day moving average price is $118.05. Xylem has a fifty-two week low of $87.40 and a fifty-two week high of $154.27. The company has a quick ratio of 1.24, a current ratio of 1.61 and a debt-to-equity ratio of 0.23. The firm has a market capitalization of $21.19 billion, a price-to-earnings ratio of 21.61, a P/E/G ratio of 1.75 and a beta of 1.00.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Tuesday, October 27th. The industrial products company reported $1.44 earnings per share for the quarter, missing analysts’ consensus estimates of $1.45 by ($0.01). Xylem had a net margin of 11.15% and a return on equity of 11.77%. The company had revenue of $2.20 billion during the quarter, compared to the consensus estimate of $2.28 billion. During the same period in the previous year, the firm posted $1.37 EPS. The business’s quarterly revenue was down 3.0% compared to the same quarter last year. On average, equities research analysts expect that Xylem will post 5.65 EPS for the current year.

Xylem Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 24th. Stockholders of record on Thursday, August 27th were given a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date of this dividend was Thursday, August 27th. Xylem’s payout ratio is currently 40.95%.

Key Xylem News

Here are the key news stories impacting Xylem this week:

• Positive Sentiment: RBC initiated coverage with a moderate buy rating and a $125 price target, implying substantial upside from recent levels. RBC also reaffirmed its buy rating, while Citigroup, BNP Paribas Exane, Stifel, and Oppenheimer maintained positive ratings despite lowering their targets. RBC Capital Reaffirms Buy Rating
• Positive Sentiment: Unusually heavy call-option activity suggests some traders are positioning for a rebound: 20,508 calls changed hands, about 771% above average volume.
• Positive Sentiment: Some analysts view the selloff as excessive relative to Xylem’s longer-term growth potential. The company’s planned divestitures and new three-segment structure could streamline operations and sharpen its strategic focus.
• Neutral Sentiment: Analyst opinion is mixed. UBS lowered its price target to $99 and assigned a neutral rating, while Stifel reduced its target to $114 but retained a buy rating. The target reductions indicate more cautious near-term expectations even though most targets remain above the current share price.
• Negative Sentiment: Xylem’s third-quarter revenue of $2.20 billion missed the $2.28 billion consensus estimate, while adjusted EPS of $1.44 was slightly below expectations. Revenue declined 3% year over year, reinforcing concerns about slowing demand. Xylem Stock Price Sinks After Q3 Results
• Negative Sentiment: Management cut its 2026 outlook, a key reason for the post-earnings decline. JPMorgan downgraded the stock to underweight and lowered its target to $90, while elevated put-option activity points to continued downside hedging. Xylem Cuts 2026 Outlook
• Negative Sentiment: A law firm announced an investigation into potential securities-law violations related to the earnings shortfall, adding a further reputational and legal risk for shareholders. Xylem Investigation Notice

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.